The Enterprise Value as of November 2025 (TTM) for Triple-S Management Corporation (GTS) is -28238000.00

According to Triple-S Management Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is -28238000.00. This represents a change of -105.04% compared to the average of 560.19M of the last 4 quarters.

Triple-S Management Corporation (GTS) Historical Enterprise Value (quarterly & annually)

How has GTS Enterprise Value performed in the past?

The mean historical Enterprise Value of Triple-S Management Corporation over the last ten years is 1.32B. The current -28238000.00 Enterprise Value has changed -314.64% with respect to the historical average. Over the past ten years (40 quarters), GTS's Enterprise Value was at its highest in in the March 2016 quarter at 2.04B. The Enterprise Value was at its lowest in in the March 2020 quarter at 328.00M.

Triple-S Management Corporation (GTS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Triple-S Management Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Triple-S Management Corporation (GTS) Average Enterprise Value

How has GTS Enterprise Value performed in the past?

The current Enterprise Value of Triple-S Management Corporation (GTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Triple-S Management Corporation (GTS) Enterprise Value vs. Peers

How is GTS’s Enterprise Value compared to its peers?

Triple-S Management Corporation’s Enterprise Value is less than Cardiovascular Systems, Inc. (797.83M), less than Harpoon Therapeutics, Inc. (829.47M), less than Avid Bioservices, Inc. (971.01M), less than Atrion Corporation (806.11M), less than Intercept Pharmaceuticals, Inc. (1.08B), less than ASLAN Pharmaceuticals Limited (782.70M), less than Chimerix, Inc. (770.49M), less than Albireo Pharma, Inc. (677.78M), less than Poseida Therapeutics, Inc. (959.32M), less than Icosavax, Inc. (718.99M),

Build a custom stock screener for Triple-S Management Corporation (GTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Triple-S Management Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Triple-S Management Corporation (GTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Triple-S Management Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.